Atrás
Rango del Día
$24.86
$27.02
Rango de 52 Semanas
$0.55
$83.60
Volumen
112,793
Promedio 50D / 200D
$28.38
/
$20.03
Cierre Anterior
$27.37
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3478.7 | 0.4 |
| P/B | 2565.4 | 2.9 |
| ROE % | -54.8 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
No hay estimaciones futuras disponibles
Puntos Clave
Debt/Equity of 0.11 — conservative balance sheet
Negative free cash flow of -3.27M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-54.81%
ROIC-52.32%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.11
Current Ratio7.39
Interest Coverage0.00
Valoración
P/E Ratio
-3478.74
P/B Ratio2565.40
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -3.58M |
| ROE | -54.81% | ROA | -62.27% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3.27M |
| ROIC | -52.32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 7.39 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3478.74 | P/B Ratio | 2565.40 |
| P/S Ratio | N/A | PEG Ratio | 136.35 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 12.47B | Enterprise Value | 12.47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -3.58M | -4.30M | -5.87M | -7.42M | -1.35M |
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| Gross Profit | -392,743.0 | -745,588.0 | -769,687.0 | -604,397.0 | -26,456.0 |
| Operating Income | -3.77M | -4.74M | -6.27M | -7.62M | -1.38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.76M | 8.44M | 12.62M | 18.02M | 340,134.0 |
| Total Liabilities | 895,308.0 | 219,512.0 | 632,320.0 | 938,032.0 | 4.34M |
| Shareholders' Equity | 4.86M | 8.22M | 12.03M | 17.07M | -4.00M |
| Total Debt | 544,415.0 | 85,741.0 | 463,669.0 | 771,255.0 | 3.68M |
| Cash & Equivalents | 2.42M | 2.96M | 1.56M | 6.42M | 59,413.0 |
| Current Assets | 4.90M | 8.11M | 11.62M | 16.44M | 66,849.0 |
| Current Liabilities | 663,673.0 | 193,578.0 | 606,914.0 | 577,764.0 | 4.34M |